Brief: Evoke Pharma Says Audit Committee Determined Previously Issued Financials Should No Longer Be Relied Upon
May 14 (Reuters) - Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA- ON MAY 13, AUDIT COMMITTEE DETERMINED
PREVIOUSLY
ISSUED FINANCIALS FOR YEAR ENDED DECEMBER 31, 2023 SHOULD NO
LONGER BE RELIED UPON
* EVOKE PHARMA - DETERMINED FINANCIALS FOR QTRLY REPORTS
FOR
PERIODS ENDED JUNE 30, 2023 AND SEPTEMBER 30, 2023 SHOULD NO
LONGER BE RELIED UPON
Source text for Eikon: ID:n0000950170-24-059477
Further company coverage: EVOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary